Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001671858-20-000002
Filing Date
2020-10-06
Accepted
2020-10-06 14:58:42
Documents
1
Effectiveness Date
2020-10-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10324
  Complete submission text file 0001671858-20-000002.txt   11450
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-377225 | Film No.: 201226472
SIC: 2834 Pharmaceutical Preparations